Metarmor Overview

  • Founded
  • 2015

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $359K

Metarmor General Information


Developer of drug for prevention of hearing loss. The company specializes in developing and commercializing a drug that protects hair cells in the inner ear for prevention of hearing loss and auditory damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 307 North Polktown Road
  • Glen Gardner, NJ 08826
  • United States
+1 (908) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Metarmor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 09-Jun-2017 $359K 00000 Completed Startup
To view Metarmor’s complete valuation and funding history, request access »

Metarmor Executive Team (1)

Name Title Board Seat Contact Info
Jennifer Seibert Chief Executive Officer & Board Member
To view Metarmor’s complete executive team members history, request access »

Metarmor Board Members (4)

Name Representing Role Since
Frances Engoron Metarmor Board Member 000 0000
Jennifer Seibert Metarmor Chief Executive Officer & Board Member 000 0000
Joseph Walker Metarmor Board Member 000 0000
Kathleen Campbell Metarmor Board Member 000 0000
To view Metarmor’s complete board members history, request access »